• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
TLRY

TLRY

Tilray Brands, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericCA

USD5.11

-0.27 (-5.02%)

Rating:C

Company Profile

CEO

Irwin David Simon

IPO Date

2018-07-19

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

CA

Market Metrics

Open

$5.33

Prev. Close

$5.38

Day Low

$5.11

Day High

$5.35

52W Low

$3.50

52W High

$23.20

Market Cap

$0.61B

Volume

3.27M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

52.9%

Avg Negative

16.9%

Avg Neutral

30.2%

News Feed

3 Cannabis Growth Stocks You Don't Want to Miss in August

The Motley Fool·7/31/2021·↑ positive

Why Tilray Is Trouncing the Market This Week

The Motley Fool·7/30/2021·↑ positive

Is Tilray Stock a Buy After Its Surprising Q4 Profit?

The Motley Fool·7/30/2021·↑ positive

Why Hexo, Tilray, OrganiGram, and Sundial Stocks Are Wilting

The Motley Fool·7/29/2021·↓ negative

Tilray Postpones Special Meeting To Solicit Proxies, Says Majority Of Shareholders Support Dilution And Other Proposals

Benzinga·7/29/2021·↓ negative

Tilray Announces Adjournment of Special Meeting of Stockholders to August 19, 2021

Business Wire·7/29/2021·↑ positive

Short Squeeze? Tilray Stock Soars On Standout Earnings

Benzinga·7/29/2021·↑ positive

Why Cannabis Giant Tilray (TLRY) Skyrocketed Today

Zacks Investment Research·7/28/2021·↑ positive

Tilray stock price predictions for August 2021 after Q4 revenue miss

Invezz·7/28/2021·↑ positive

Here's why Tilray shares are up nearly 30% on Wednesday

Invezz·7/28/2021·↑ positive